How it works:
Atazanavir inhibits HIV-1 protease, preventing viral maturation
Ritonavir boosts atazanavir levels by inhibiting its metabolism
The combination maintains stable plasma concentrations of the main drug
Used in combination with other antiretrovirals for effective viral suppression
Recommended for:
Adults diagnosed with HIV-1 infection
Patients already receiving antiretroviral therapy
Individuals requiring boosted protease inhibitor regimens
As prescribed by an infectious disease specialist
Treatment of HIV-1 infection in adults as part of combination antiretroviral therapy.
Take orally once daily with food. Dosage and treatment duration are determined by the physician based on the specific regimen and patient condition.
Contraindications:
Known hypersensitivity to any component
Severe hepatic impairment
Co-administration with drugs that reduce atazanavir levels
Under 18 years of age
Side effects:
Jaundice
Hyperbilirubinaemia
Diarrhoea
Nausea
Elevated liver enzymes
Headache
Fat redistribution
